A comparative study on hepatocellular carcinoma between South Africans and Japanese from the viewpoint of nuclear DNA content. by Yoshida, Y. et al.
Br. J. Cancer (1994), 69, 362 366
© Macmillan Press Ltd.,
A comparative study on hepatocellular carcinoma between South Africans
and Japanese from the viewpoint of nuclear DNA content
Y. Yoshidal,* T. Kanematsu't, T. Matsumata', K. Sugimachi', M.C. Kew2 & A.C. Paterson3
'Second Department ofSurgery, Faculty ofMedicine, Kyushu University, Fukuoka, Japan; 2Department ofMedicine and
'Experimental Pathology Unit, University ofthe Witwatersrand, Johannesburg, South Africa.
Summary Nuclear deoxyribonucleic acid (DNA) content of hepatocellular carcinoma (HCC) in 41 South
African and 47 Japanese patients at autopsy was analysed by dual-wavelength microspectrophotometry. The
DNA distribution patterns were classified as type I, II, III or IV and as low ploidy (types I, II) or high ploidy
(types III, IV), according to the degree of dispersion. We found a significantly higher incidence of high ploidy
in South African HCC than in Japanese HCC. Moreover, type IV was significantly more frequent among
South Africans than among the Japanese. These findings demonstrate that large differences in biological
characteristics and clinical behaviour of HCC between South Africa and Japan may reflect differences in DNA
distribution patterns which we observed between these two races.
HCC is one of the most frequent malignant solid tumours in
many countries, particularly in sub-Saharan Africa and the
Far East (Okuda & Nakashima, 1985; Okuda, 1990), and the
prognosis is poor (Harington et al., 1975; Kew & Geddes,
1982; Okuda, 1990). Moreover, according to some reports
the occurrence of this neoplasm is steadily increasing (Saracci
& Repetto, 1980; Munoz & Bosch, 1987; Okuda et al., 1987).
Ofparticular interest are outstanding geographical and ethnic
differences in frequency, clinical behaviour and histo-
pathology (Okuda et al., 1984; Okuda, 1990).
The incidence of HCC in Japan is intermediate (Saracci &
Repetto, 1980; Munoz & Bosch, 1987), whereas among South
African black males, particularly gold miners from Mozam-
bique, it is extremely high (Kew & Geddes, 1982; Okuda &
Nakashima, 1985; Munoz & Bosch, 1987). With respect to
resectability, Maraj et al. (1988) reported that in South
Africa only 2 of 223 patients (2.4%) with histologically diag-
nosed HCC had a resectable tumour and that one patient
underwent a successful hepatectomy. By contrast, the Liver
Cancer Study Group of Japan reported that the resectability
rate in Japanese patients with HCC is 18.1% (2,334/12,887)
(The Liver Cancer Study Group Japan, 1990). From the histo-
pathological viewpoint, HCC in South Africa is much more
often poorly differentiated, multifocal and infiltrative, and
faster growing than in Japan. Moreover, concomitant cirrhotic
changes are much less common than in the Japanese (Kew,
1989; Okuda, 1990). When HCC in South Africans is associ-
ated with cirrhosis, it is almost invariably macronodular, and
HCC among South African blacks is frequently multifocal
and infiltrates surrounding tissue, in contrast to HCC in the
Far East, which is more often unifocal or oligofocal
(Nakashima et al., 1982; Okuda et al., 1984; Kew, 1989;
Okuda, 1990). The frequency of encapsulated types of HCC
is much higher in the Japanese than in the South Africans,
and such types of HCC are said to be relatively benign
(Okuda et al., 1977, 1984; Okuda & Nakashima, 1985).
Cellular DNA content of HCC has been determined using
static cytophotometry (Koike et al., 1982; Kuo et al., 1987a,
b; Ezacki et al., 1988) or flow cytometry (Chen et al., 1991;
Fujimoto et al., 1991; McEntee et al., 1992; Nagasue et al.,
1992). However, comparative studies concerning nuclear
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DNA of HCC between different geographical areas have
apparently not been reported.
We investigated the reasons for the distinct clinical and
histopathological differences in HCC between South Africans
and the Japanese. We asked whether differences in nuclear
DNA content of HCC between these races would explain
geographical and ethnic differences in HCC.
Materials and methods
Tissue specimens from 41 South African black patients and
47 Japanese patients with HCC were examined. All the
materials were obtained at autopsy because of the rarity of
surgical treatment for such patients in South Africa. For
cytophotometric measurements of cell nuclear DNA content,
we used tissue specimens obtained from South African Black
patients between 1975 and 1986 at the University Hospital of
the Witwatersrand, and from Japanese patients between 1971
and 1986 at Kyushu University Hospital. Fibrolamellar
variant was not included. Very few patients had chemo-
therapy before death, mainly because of refusal of any treat-
ment, or because of deteriorating clinical state. For entry into
the present study, we tried to select patients from consecutive
autopsy records on whom autopsy was done within 11- 12 h
after death and who had not been on chemotherapy, especi-
ally through intra-arterial or intravenous routes.
The histological classification of HCC was based on the
grade of differentiation and the criteria of the World Health
Organization (Gibson & Sobin, 1978).
Prior to this comparative study, using microspectro-
photometry we first confirmed that the DNA distribution
pattern in one portion of the tumour was representative of
the DNA pattern of the tumour. Nuclear DNA content was
measured by dual-wavelength microspectrophotometry of
paraffin-embedded sections. Tissue specimens were immedi-
ately fixed in 10% formalin and embedded in paraffin; then,
4-.tm-thick sections were stained with haematoxylin and eosin
(H&E). After histological confirmation of the nature of the
neoplasm, 10- to 13 j.m-thick section were taken just adjacent
to the portion assessed by H&E staining. After Feulgen
DNA staining with a Schiff-type dye (Leuchtenberger, 1950;
Schrader & Leuchtenberger, 1950; Leuchtenberger et al.,
1951; Naora, 1955), the nuclear DNA content was analysed
by the dual-wavelength method using a microspectro-
photometer (MPV III, E. Leitz, Germany) at 500 and
570 nm, to avoid inaccuracies due to overlapping, cutting of
nuclei or interfering light absorption by other nuclei (Patau,
1952; Mendelsohn, 1958). To differentiate mononucleated
cancer cells from binucleated ones, we analysed the nuclear
DNA content after confirming the cell to be mononucleated,
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by changing the focus of the microspectrophotometer on the
specimen. The data were processed using a personal com-
puter (HP-85, Hewlett Packard, USA). The diploid value
(2C) was determined using the mean value of 24-25 stromal
lymphocytes as the control. The lymphocytes used as the
internal control and the cancer cells analysed were from the
same section, thus lymphocytes and cancer cells were
measured under the same conditions. Then, 100-105
mononucleated cancer cells in the hepatic parenchyma were
measured, and a histogram of the DNA content relative to
the control was determined. The DNA distribution patterns
were grouped according to the degree of dispersion into four
types and low and high ploidy as described elsewhere (Figure
1) (Yoshida et al., 1988; Baba et al., 1990).
Low ploidy
I No cells over 6C.
II Cells over 6C did not surpass 10%.
High ploidy
III Cells over 6C surpassed 10% but did not surpass
20%.
IV Cells over 6C surpassed 20%.
Student's t-test and the chi-square test were used to deter-
mine the statistical significance of differences.
Results
Clinical characteristics
The patients' backgrounds are given in Table I. South
African patients were significantly younger than Japanese
patients (P<0.0001), and the male-female ratio of South
African patients was significantly higher than that of
Japanese patients (P<0.05). The median age of South
African and Japanese patients was 40 and 59 years respec-
tively. These differences reflect the proportion of mine
workers in the South African series. The number of patients
who tested positive for hepatitis B surface antigen was
significantly higher in South African patients (P<0.05).
There were no significant differences in other biochemical
parameters of liver function.
Nuclear DNA distribution pattern
The mean C value, modal C value, percentage of cells with
over 6C and percentage of cells with over 4C in specimens
from South African and Japanese patients are shown in
Table II. The mean DNA content of tissue specimens from
South African patients was significantly higher than that of
specimens from Japanese patients (P<0.0005). The mean
mode value was significantly higher in specimens from South
African patients (P<0.0005). Moreover, significant differ-
ences between these two groups were observed regarding the
percentage of cells with more than 6C (P<0.01) and more
than 4C (P<0.001).
Figure 2 illustrates the distribution of the mean DNA
content of HCCs. The highest peak of the mean DNA con-
tent of HCC for the South Africans lies between SC and 6C,
whereas that among the Japanese lies between 4C and SC.
Furthermore, 66% (27/41) of HCC tissue specimens from
South African patients had a mean DNA content of more
than 5C. In contrast, 77% (36/47) of HCC of tissue speci-
mens from Japanese patients had a mean DNA content of
less than 5C.
Figure 3 shows the distribution of HCC among South
African and Japanese patients, according to the type of DNA
pattern. The percentage of South African patients with HCC
with a type IV DNA pattern was significantly greater than
that of Japanese patients (P<0.01). As for ploidy, the
percentage of South African patients with high-ploidy HCC
was significantly higher than that of Japanese patients
(P<0.05).
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Figure 1 Representative histograms of HCC in types I-IV, and
low and high ploidy classes. C values express DNA content as
multiples of the haploid values obtained from lymphocytes in the
same sections as the carcinoma cells.
Table I Background of patients
South Africans Japanese
(n = 41) (n = 47) P-value
Age (years) 42.9 ± 16.5 58.7 ± 8.5 <0.0001
(range) (13-81) (42-78)
Male-female 39:2 38:9 <0.05
ratio (%) (19.5:1) (4.2:1)
HBs-Ag (+) (%) 46.4 29.8 <0.05
AFP (ng ml-') 153,283 ± 243,300 108,146 ± 217,875 NS
Frequency of 83.4 86.4 NS
positive AFP (%)
Albumin (g dl-') 3.4 ± 0.6 3.3 0.6 NS
T.Bil. (mgdl-') 6.4± 5.7 7.2± 10.1 NS
AST (Udl') 154± 139 165± 104 NS
ALT (Udl') 72 ± 53 102 121 NS
ALP (Udl') 238 ± 176 262 176 NS
Abbreviations: HBs-Ag, hepatitis B surface antigen; AFP, alpha-fetoprotein; T.Bil.,
total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase;
ALP, alkaline phosphatase; NS, not significant.
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Table II The mean and modal C values, and percentage of cells
over 6C and 4C, from HCC in South African and Japanese patients.
C values are given as multiples of the haploid DNA value (in
arbitary units) obtained in the same sections as described in
Materials and methods and the legend to Figure 1
South Africans Japanese P-value
Mean C value 5.54± 1.31 4.43 0.99 0.0003
Mode C value 5.0 ± 1.3 3.9 ± 1.0 0.0004
Over 6C (%) 35 26 15± 16 0.009
Over 4C (%) 77 ± 27 54 24 0.0006
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Figure 2 Distribution of the mean DNA content of HCC tissues
from South African ( ) (n
= 41) and Japanese ( ) patients
(n = 47). Numbers and numbers in parentheses indicate the
percentage and the actual number respectively.
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Figure 3 Distribution of DNA content according to type (type I,
II, III or IV) and ploidy (low or high). Narrow columns represent
types I-IV and wide columns represent low or high ploidy.
Numbers and numbers in parentheses indicate the percentage and
the actual number respectively. ( M ), South Africans (n = 41);
( ), Japanese (n = 47).
Pathologicalfindings
Table III summarises the data on microscopic findings and
the pathology. There was a significant difference in liver
weight between the two groups (3,356 g vs 2,015 g, P<0.05),
however, data on the tumour size were not available. The
prevalence of liver cirrhosis was significantly lower among
South African patients (54.3% vs 97.4%, P<0.01). Histo-
logically, the prevalence of poorly differentiated HCC was
significantly higher among South African blacks (53.8% vs
25.8%, P<0.05). According to classification of the World
Health Organization, no significant differences were recog-
nised between the two groups.
Discussion
In the present study, we found that, compared with Japanese
patients, South African black patients with HCC were
younger, the male-female ratio was greater, the rate of
patients for positive hepatitis B surface antigen was higher,
the livers were larger, the rate of patients with cirrhotic
changes in the non-cancerous liver was lower and the car-
cinomas were less differentiated. These observations are con-
sistent with those in the literature (Kew & Geddes, 1982;
Nakashima et al., 1982; Okuda et al., 1984, 1985; Paterson et
al., 1985; Kew, 1989; Okuda, 1990).
With respect to correlations between the difference in
tumour size and the presence or absence of cirrhosis, there
was no information on tumour size for 22 of the 47 Japanese
patients and often permission was given for only a limited
autopsy on many South African patients. Therefore, we
could not determine whether the difference in the DNA
content between two races may relate to differences in
tumour size or accompanying cirrhosis.
There are apparently no reports in the literature relating to
geographical and ethnic differences in nuclear DNA content
of HCC. However, Sugimachi et al. (1987) compared Chinese
and Japanese patients with oesophageal cancer with regard to
cell nuclear DNA content, using the same methodology as
used in the present study. According to their results, the
prognosis of patients with high-ploidy DNA patterns was
Table III Pathological findings in South African and Japanese patients with
HCC
South Africans Japanese
(n =41) (n = 47) P-value
Liver weight (g) 3356 ± 1339 2015 ± 825 <0.05
Cirrhosis (+) (%) 54.3 97.4 <0.01
Fibrosis (+) (%) 8.6 0 NS
Differentiation (%) <0.05
Well to moderate 46.2 71.0
Poor 53.8 29.0
WHO classificationa (%) NS
Trabecular 72.8 67.7
Trabecular-pseudoglandular 12.8 9.7
Trabecular-compact 0 3.2
Pseudoglandular 7.7 0
Compact 0 3.2
Undifferentiated 7.7 2.2
aThe World Health Organization's criterion for HCC (Gibson & Sobin, 1978).
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poor in both countries, whereas there were no significant
differences between the two areas with respect to the nuclear
DNA content of oesophageal cancer tissue obtained at
surgery. In contrast, the results of the present study suggest
that there are geographical and racial differences in nuclear
DNA content with regard to DNA type, DNA ploidy, the
mean DNA value, the modal DNA value and percentage of
cells with over 6C and 4C. Furthermore, it has been reported
that tumours with increased DNA content and a higher
frequency of high-ploidy cells show higher mitotic rates. Such
tumours are more likely to metastasise and invade surround-
ing tissues, and consequently their rate of resectability is low
(Korenaga et al., 1988). Considering these findings, there
seems to be a close relation between clinical and histological
characteristics of HCC and nuclear DNA content.
Bohm and Sandritter (1975) noted the stability of cellular
DNA for various kinds of tumours, using static cyto-
photometry. On the other hand, they also observed that
nuclear DNA content varies in the course of tumour growth,
from precancer to invasive carcinoma, in case of uterine
cervix and skin cancers. However, Kuo et al. (1987b) sug-
gested that the DNA stemline of primary HCC and its
subcutaneous metastases may be the same, based on their
findings in aspirated specimens, albeit from only two
patients. With respect to the stability of the DNA pattern of
HCC, we have proposed a possible relationship between the
DNA distribution pattern and the biological characteristics
of the growth pattern of HCC (Ezaki et al., 1988; Yoshida et
al., 1992). We have also reported that the nuclear DNA
content of HCC in autopsy specimens is not always stable
and that ofprimary lesions may differ from the nuclear DNA
content in metastatic pulmonary lesions, that is the DNA
pattern may change during tumour growth (Yoshida et al.,
1992). The DNA pattern appears to be a stable indicator of
tumour characteristics and it is likely to change during the
course of tumour growth. In the present study, we examined
specimens taken at the terminal stage of the disease; thus our
results correspond to the DNA distribution pattern of HCC
in the final stage. Hence, we speculate that high ploidy was
greater in South African HCC than in Japanese HCC, from
the onset of HCC, or that the DNA distribution pattern of
the tumour in South African HCC varies and DNA content
increases more rapidly than in Japanese HCC as the tumour
develops and becomes more invasive.
The present study shows large geographical and ethnic
differences in biological characteristics and clinical behaviour
of HCCs between South Africans and the Japanese and
reflects differences in nuclear DNA content. Analyses of
nuclear DNA content of HCC are thus considered beneficial
to estimate the extent of malignancy of this neoplasm.
A.C. Paterson was sponsored in part by the South African Medical
Research Council. We thank M. Ohara for editing the language in
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